I hope Health Canada will fast-track the new #ADHD drug, #Centanafadine, too, because my #Vyvanse is doing a number on my blood pressure and my (already menopause compromised) sleep!🧠 💗 😵‍💫

#Centanafadine, a potential first-in-class NDSRI, showed sustained symptom improvement and was well tolerated over 52 weeks in adults with #ADHD. No signs of abuse or withdrawal. A promising #nonstimulant option.

🔗 Read more in our current issue: journals.lww.com/psychopharma...